At TLC, we develop novel nanomedicines that maximize the potential of our lipid-based drug delivery technologies. We are currently focused on creating new therapies in the areas of oncology, ophthalmology and osteoarthritis.

Industries

Employees

51-200

Links


Org chart

Collapse

Teams


Offices